Tamer joined the company in October 2008 as Sales Director, bringing with him over 15 years of experience in the biotechnology and pharmaceutical industries, in 2013 he has promoted to the position of General Manager. Under his leadership, the total turnover of Biopharma raised to exceed $ 140 Millions. Biopharma-MEA is now a Middle East pharmaceutical company with presence across the Middle East markets and with total number of employees exceeding 75 employee.
From January 2005 till end of December 2007. Tamer served as Country Manager for Saudi Arabia at Serono pharmaceuticals, responsible for product portfolio including infertility and neurology innovative biotech products. Under his leadership, the company has improved significantly its market shares in the Saudi markets, and has successfully achieved its top and bottom lines targets. Following the acquisition of Serono pharmaceuticals by Merck KGoA, Tamer has been moved to the role of Business Director – South Gulf at MerckSerono. During his leadership, the company has been able to improve its business infrastructure and strengthen its position in the South Gulf region.
Tamer is a pharmacist, with Bachelor degree of pharmaceutical sciences from Alexandria university, Egypt. He received a M.B.A degree from Strathclyde Business School, Scotland, in 2007.